These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 11372668)

  • 1. The impact of dalteparin (Fragmin) on thrombin generation in pregnant women with venous thromboembolism: significance of the factor V Leiden mutation.
    Schambeck CM; Eberl E; Geisen U; Grossmann R; Keller F
    Thromb Haemost; 2001 May; 85(5):782-6. PubMed ID: 11372668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden.
    Eichinger S; Weltermann A; Philipp K; Hafner E; Kaider A; Kittl EM; Brenner B; Mannhalter C; Lechner K; Kyrle PA
    Thromb Haemost; 1999 Oct; 82(4):1232-6. PubMed ID: 10544904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trial.
    Abou-Nassar K; Kovacs MJ; Kahn SR; Wells P; Doucette S; Ramsay T; Clement AM; Khurana R; Mackinnon K; Blostein M; Solymoss S; Kingdom J; Sermer M; Rey E; Rodger M;
    Thromb Haemost; 2007 Jul; 98(1):163-71. PubMed ID: 17598009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.
    Martinelli I; De Stefano V; Taioli E; Paciaroni K; Rossi E; Mannucci PM
    Thromb Haemost; 2002 May; 87(5):791-5. PubMed ID: 12038778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus.
    Dizon-Townson D; Miller C; Sibai B; Spong CY; Thom E; Wendel G; Wenstrom K; Samuels P; Cotroneo MA; Moawad A; Sorokin Y; Meis P; Miodovnik M; O'Sullivan MJ; Conway D; Wapner RJ; Gabbe SG;
    Obstet Gynecol; 2005 Sep; 106(3):517-24. PubMed ID: 16135581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The assay of overall haemostasis potential used to monitor the low molecular mass (weight) heparin, dalteparin, treatment in pregnant women with previous thromboembolism.
    Antovic A; Blombäck M; Bremme K; He S
    Blood Coagul Fibrinolysis; 2002 Apr; 13(3):181-6. PubMed ID: 11943930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thrombotic risk in family members of unselected individuals with factor V Leiden.
    Lensen RP; Bertina RM; de Ronde H; Vandenbroucke JP; Rosendaal FR
    Thromb Haemost; 2000 Jun; 83(6):817-21. PubMed ID: 10896231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
    Martinelli I; Legnani C; Bucciarelli P; Grandone E; De Stefano V; Mannucci PM
    Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low molecular weight heparin (dalteparin) for the treatment of venous thromboembolism in pregnancy.
    Jacobsen AF; Qvigstad E; Sandset PM
    BJOG; 2003 Feb; 110(2):139-44. PubMed ID: 12618157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between inherited thrombophilias, antiphospholipid antibodies, and lipoprotein A levels and venous thromboembolism in pregnancy.
    Ogunyemi D; Cuellar F; Ku W; Arkel Y
    Am J Perinatol; 2003 Jan; 20(1):17-24. PubMed ID: 12638077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor V Leiden mutation and the risk of venous thromboembolism in pregnant women.
    Tormene D; Simioni P; Prandoni P; Luni S; Zerbinati P; Sartor D; Franz F; Girolami A
    Haematologica; 2001 Dec; 86(12):1305-9. PubMed ID: 11726323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous thrombin potential for predicting risk of venous thromboembolism in carriers of factor V Leiden.
    Lincz LF; Lonergan A; Scorgie FE; Rowlings P; Gibson R; Lawrie A; Seldon M
    Pathophysiol Haemost Thromb; 2006; 35(6):435-9. PubMed ID: 17565236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism.
    Libourel EJ; Bank I; Meinardi JR; Baljé -Volkers CP; Hamulyak K; Middeldorp S; Koopman MM; van Pampus EC; Prins MH; Büller HR; van der Meer J
    Haematologica; 2002 Oct; 87(10):1068-73. PubMed ID: 12368162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction, prevention, and treatment of venous thromboembolic disease in pregnancy.
    Zotz RB; Gerhardt A; Scharf RE
    Semin Thromb Hemost; 2003 Apr; 29(2):143-54. PubMed ID: 12709917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous thromboembolism during pregnancy or postpartum: findings from the RIETE Registry.
    Blanco-Molina A; Trujillo-Santos J; Criado J; Lopez L; Lecumberri R; Gutierrez R; Monreal M;
    Thromb Haemost; 2007 Feb; 97(2):186-90. PubMed ID: 17264945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.
    Abramson N; Costantino JP; Garber JE; Berliner N; Wickerham DL; Wolmark N
    J Natl Cancer Inst; 2006 Jul; 98(13):904-10. PubMed ID: 16818854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboprophylaxis with low molecular mass heparin, 'Fragmin' (dalteparin), during pregnancy--a longitudinal safety study.
    Blombäck M; Bremme K; Hellgren M; Siegbahn A; Lindberg H
    Blood Coagul Fibrinolysis; 1998 Jan; 9(1):1-9. PubMed ID: 9607113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor V Leiden and prothrombin G20210A gene mutations in women with a history of thrombosis during pregnancy. Relation to pregnancy outcomes for mother and fetus.
    Abu-Skeen IA; Mohamed AA; Moustafa NN; Badawy ME
    Saudi Med J; 2010 Feb; 31(2):123-9. PubMed ID: 20174725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
    Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
    Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombogenesis in Thrombophilic Pregnancy: Evaluation of Low-Molecular-Weight Heparin Prophylaxis.
    Simeone R; Giacomello R; Bruno G; Parco S; Maximova N; Martinelli M; Zito G; Luppi S; Cervi G; Ricci G
    Acta Haematol; 2017; 137(4):201-206. PubMed ID: 28478442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.